Roche fined for hindering entry of generic cancer drugs

Charley Connor

24 January 2020

Roche fined for hindering entry of generic cancer drugs

Credit: Grand Warszawski/Shutterstock

Romania’s Competition Council has fined F. Hoffmann-La Roche’s local subsidiary €12.8 million for abusing its dominance in multiple cancer treatment markets, but the drugmaker has accused the enforcer of acting in bad faith and ignoring evidence of its innocence.